文献速递心外重症与机械循环支持

离心泵与轴流泵左心室辅助装置支持期间主动脉瓣关闭不全的进展

Progression of aortic valve insufficiency during centrifugal versus axial flow left ventricular assist device support.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

该回顾性研究比较了HeartMate 2(HM2)与HeartMate 3(HM3)左心室辅助装置支持患者进展至中度或重度主动脉瓣关闭不全(MSAI)的速率。共纳入536例HM2和300例HM3患者,评估4005份超声心动图。HM2组进展至MSAI的比例为17%,HM3组为9.9%;单变量分析HM3的风险比为0.581(95%CI 0.370-0.909,P=0.02),多变量分析风险比为0.624(95%CI 0.386-1.008,P=0.0537)。

要点

  • HM2组进展至MSAI的比例为17%,HM3组为9.9%。
  • 术前主动脉瓣关闭不全、女性和体表面积<2是进展至MSAI的重要预测因素。
  • 泵类型对进展至MSAI的作用似乎是次要的。

核心结论

  • 当前实践策略下进展至MSAI的速率较低。
  • 术前主动脉瓣关闭不全、女性和体表面积<2是进展至MSAI最重要的预测因素。
  • 泵类型似乎是次要的。

研究设计与样本

  • 回顾性综述,纳入2005年5月至2020年6月间连续植入HM2或HM3的所有患者。
  • 随访时间限制在左心室辅助装置植入后前6年。
  • 评估了536例HM2和300例HM3患者的人口统计学资料和4005份超声心动图。
  • 主要终点为进展至MSAI。
  • 进行了单变量和多变量Cox比例风险回归及界标分析。

主要发现

  • HM2组进展至MSAI的比例为17%,HM3组为9.9%。
  • 单变量分析中,HM3的风险比为0.581(95%CI 0.370-0.909,P=0.02)。
  • 多变量分析中,HM3的风险比为0.624(95%CI 0.386-1.008,P=0.0537)。
  • 术前主动脉瓣关闭不全、女性和体表面积<2与进展至MSAI显著相关。
  • 界标分析提示,左心室辅助装置类型对进展至MSAI的影响在植入后1至2年间最显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Long-term left ventricular assist device (LVAD) support can cause accelerated progression of aortic insufficiency (AI). The MOMENTUM trial has led to increased use of the HeartMate 3 (HM3) LVAD, due to greater hemocompatibility. However, the differential effect on the rate of progression of AI during HM3 support versus HeartMate 2 (HM2) has not been extensively studied. This analysis compares the rates of progression to moderate or severe AI (MSAI) comparing a cohort of patients supported with the HM2 versus HM3. METHODS: A retrospective review was performed on all consecutive patients implanted with HM2 or HM3 between May 2005 and June 2020. Follow-up time was limited to the first 6 years after LVAD implantation. Demographics and 4005 echocardiograms were assessed for 536 HM2 and 300 HM3 patients. The primary end point was progression to MSAI. Univariable and multivariable Cox proportional hazard regression and landmark analyses were performed. RESULTS: Progression to MSAI was greater in the HM2 (17%) versus HM3 (9.9%) cohort. On the univariable analysis, the hazard ratio for HM3 was 0.581 (95% confidence interval 0.370-0.909, P = 0.02) whereas on multivariable analysis hazard ratio was 0.624 (95% confidence interval 0.386-1.008, P = 0.0537). Preoperative AI, female sex and body surface area <2 were significantly associated with progression to MSAI. Landmark analysis suggests that LVAD type has the most significant effect on progression to MSAI between 1 and 2 years post-implantation. CONCLUSIONS: Current practice strategies achieved low rates of progression to MSAI. Preoperative AI, female sex and body surface area <2 were the most important predictors of progression to MSAI. Pump type appears to be of secondary importance.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Jimenez Contreras F, Mendiola Pla M, Schroder J, et al. Progression of aortic valve insufficiency during centrifugal versus axial flow left ventricular assist device support. Eur J Cardiothorac Surg. 2022. PMID: 35167677. doi:10.1093/ejcts/ezac087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。